All
Experimental therapy figures to save limbs
January 1st 2003Cambridge, Mass. - An experimental therapy that makes use of fibroblast growth factor type 1 (FGF-1) encoded in naked plasmid DNA (NV1FGF) could save the limbs of patients afflicted with chronic wounds due to critical leg ischemia associated with peripheral arterial disease (PAD), according to Vincent Li, M.D., M.B.A.
Randomized, controlled, blinded study finds dermasanding beneficial
January 1st 2003Toronto - Refinement of immature scars with dermasanding is a safe, simple and low-cost technique for improving final cosmetic outcome, according to the results of an investigator-blinded, controlled study undertaken by Elena Poulos, M.D., and colleagues from the division of dermatology, Sunnybrook and Women's College Hospital, University of Toronto, Canada.
Injectable Silicone Shows Promisefor Treatment of HIV-associated Facial Lipoatrophy
January 1st 2003Chicago -- Off-label experience using injectable silicone (Silikon 1000) in an investigational protocol indicates it is a highly effective and, thus far, very safe modality for treating facial lipoatrophy in HIV-infected patients, Derek H. Jones, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.
Management beyond corticosteriods starts with assessing risk to skin, reducing sun exposure
January 1st 2003Paris - Treatment for dermatomyositis (DM) begins with sun avoidance and sun-protective measures, Jeffrey P. Callen, M.D., said at the World Congress of Dermatology. "The first line of therapy is to recognize that the patient is photosensitive."
Staphylococcus Aureus Virulence
January 1st 2003San Diego - Ominous episodes of furunculosis due to an unusual strain of methicillin-resistant Staphylococcus aureus (MRSA) appeared suddenly among a classroom of third-grade students in a Swiss village. Some boils were so severe and painful the children had to be hospitalized for surgical drainage and IV antibiotics, a Swiss/French research team reported at the recent Interscience Conference on Antimicrobial Agents and Chemotherapy.